The rising demand for improved aseptic handling, greater reproducibility and reduced errors have prompted the biopharmaceutical companies to consider shifting from manually operated sampling systems to automatic sampling systems
Roots Analysis is pleased to announce the publication of its recent study, titled, “Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035” report to its list of offerings.
The report features an extensive study on the current and future potential of automatic sampling systems. Due to the growing demand for biologics and stringent regulatory guidelines, the biopharmaceutical industry has shifted to using automatic sampling methods, which offer reliable systems for transferring bioprocess samples directly from bioreactors to analytical devices while maintaining the process sterility and integrity. In addition, it features an elaborate discussion on the likely opportunity for the players engaged in this domain, over the next decade. Amongst other elements, the automatic sampling market report includes:
§ A detailed assessment of the current market landscape of automatic sampling systems and their manufacturers.
§ A competitiveness analysis of automatic sampling systems manufacturers.
§ Elaborate profiles of prominent players engaged in the manufacturing of automatic sampling systems (shortlisted on the basis of company size).
§ A detailed market landscape of automatic sample collection / preparation systems and their manufacturers.
§ Detailed profiles of the players offering automatic sample collection / preparation systems (shortlisted on the basis of the number of systems manufactured).
§ An insightful analysis of the patents filed / granted for automatic sampling systems, since 2016.
§ An analysis of various developments / recent trends related to automatic sampling systems.
§ A discussion on affiliated trends, key drivers and challenges, under a SWOT framework.
§ A qualitative analysis, highlighting the five competitive forces prevalent in the automatic sampling domain.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
§ Type of Monitoring Method
§ On-line
§ Off-line
§ At-line
§ Bioprocessing Method
§ Upstream
§ Downstream
§ Working Volume
§ Less than 10 mL
§ 10-50 mL
§ 51-100 mL
§ More than 100 mL
§ Scalability
§ Lab
§ Pilot
§ Commercial
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific and Rest of the World
Key companies covered in the report
§ Agilent Technologies
§ Cytiva
§ Mettler Toledo
§ Pall Corporation
§ Shimadzu
§ Xylem
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/automatic-sampling-market.html
You may also be interested in the following titles:
Digital Biomanufacturing Market
You may also like to learn what our experts are sharing in Roots educational series:
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
Exploring How Artificial Intelligence Is Transforming Digital Pathology
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
#AutomaticSamplingMarket #AutomaticSamplingMarketSize #automaticsamplinginbiopharmaceuticals #asepticsampling #samplingmarket
